Systemic amyloidosis is a rare protein misfolding and deposition disorder leading to
progressive organ failure. There are over 15 types of systemic amyloidosis, each caused by …

Amyloid light chain (AL) amyloidosis is among the more common and more severe of the
amyloidoses usually involving the slow proliferation of a bone-marrow-residing plasma cell …

Cardiac amyloidosis is a serious and progressive infiltrative disease that is caused by the
deposition of amyloid fibrils at the cardiac level. It can be due to rare genetic variants in the …

Cardiac amyloidosis is a serious and progressive infiltrative disease that is caused by the
deposition of amyloid fibrils at the cardiac level. It can be due to rare genetic variants in the …

The recent decades have ushered in considerable advancements in the diagnosis and
treatment of systemic light chain (AL) amyloidosis. As disease outcomes improve, AL …

The treatment options for systemic light chain amyloidosis (AL) are currently widening in an
unprecedented way, brought about by an expanding arsenal of anti-myeloma therapy as …

Amyloidosis is a disorder of protein misfolding and metabolism in which insoluble fibrils are
deposited in various tissues, causing organ dysfunction and eventually death. Out of the 60 …

Cardiac Amyloidosis is an infiltrative cardiomyopathy which occurs secondary to deposition
of mis-folded protein in the myocardium, with the two most common subtypes being AL …

Amyloidosis is a group of disorders characterized by a misfolded protein that deposits in
organs and compromise their function. Clinician should have a high index of suspicion …

Electrophysiological aspects of cardiac amyloidosis (CA) are still poorly explored compared
to other aspects of the disease. However, electrocardiogram (ECG) abnormalities play an …